AETHLON MEDICAL, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
AETHLON MEDICAL, INC. (AEMD) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$5.27 million for the 9-month period ending 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-02-12
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$2.02M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$1.75M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$2.81M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$2.57M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$12.03M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$10.42M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$7.89M.
- AETHLON MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$6.38M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | -$5.27M 10-Q · filed 2026-02-12 | |||
| 2025-09-30 | -$3.25M 10-Q · filed 2025-11-12 | ||||
| 2024-12-31 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | -$4.56M derived: sum of 2 quarters · filed 2026-02-12 | -$7.13M 10-Q · filed 2026-02-12 | ||
| 2024-09-30 | -$2.81M 10-Q · filed 2024-11-13 | -$5.38M 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | -$2.57M 10-Q · filed 2024-11-13 | ||||
| 2023-12-31 | -$3.47M 10-Q · filed 2024-02-14 | -$6.50M derived: sum of 2 quarters · filed 2024-11-13 | -$9.78M derived: sum of 3 quarters · filed 2024-11-13 | -$12.25M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-09-30 | -$3.03M 10-Q · filed 2024-11-13 | -$6.32M derived: sum of 2 quarters · filed 2024-11-13 | -$8.78M derived: sum of 3 quarters · filed 2024-11-13 | -$11.63M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$3.28M 10-Q · filed 2024-11-13 | -$5.75M derived: sum of 2 quarters · filed 2024-11-13 | -$8.60M derived: sum of 3 quarters · filed 2024-11-13 | -$12.41M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-03-31 | -$2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | -$5.32M derived: sum of 2 quarters · filed 2024-02-14 | -$9.12M derived: sum of 3 quarters · filed 2024-02-14 | -$12.03M 10-K · filed 2023-06-28 | |
| 2022-12-31 | -$2.85M 10-Q · filed 2024-02-14 | -$6.66M derived: sum of 2 quarters · filed 2024-02-14 | -$9.56M 10-Q · filed 2023-02-13 | -$13.35M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | -$3.81M 10-Q · filed 2024-02-14 | -$6.71M derived: sum of 2 quarters · filed 2024-02-14 | -$10.50M derived: sum of 3 quarters · filed 2024-02-14 | -$13.03M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | -$2.91M 10-Q · filed 2024-02-14 | -$6.69M derived: sum of 2 quarters · filed 2024-02-14 | -$9.22M derived: sum of 3 quarters · filed 2024-02-14 | -$11.23M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | -$3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | -$6.31M derived: sum of 2 quarters · filed 2023-06-28 | -$8.32M derived: sum of 3 quarters · filed 2023-06-28 | -$10.42M 10-K · filed 2023-06-28 | |
| 2021-12-31 | -$2.53M 10-Q · filed 2023-02-13 | -$4.54M derived: sum of 2 quarters · filed 2023-02-13 | -$6.64M 10-Q · filed 2023-02-13 | -$8.90M derived: sum of 4 quarters · filed 2023-02-13 | |
| 2021-09-30 | -$2.01M 10-Q · filed 2023-02-13 | -$2.01M 10-Q · filed 2021-11-09 | -$4.11M 10-Q · filed 2021-11-09 | -$6.37M derived: sum of 3 quarters · filed 2023-02-13 | -$8.82M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | -$2.10M 10-Q · filed 2023-02-13 | -$4.36M derived: sum of 2 quarters · filed 2023-02-13 | -$6.81M derived: sum of 3 quarters · filed 2023-02-13 | -$8.58M derived: sum of 4 quarters · filed 2023-02-13 | |
| 2021-03-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-28 | -$4.71M derived: sum of 2 quarters · filed 2022-06-28 | -$6.48M derived: sum of 3 quarters · filed 2022-06-28 | -$7.89M 10-K · filed 2022-06-28 | |
| 2020-12-31 | -$2.44M 10-Q · filed 2022-02-14 | -$4.22M derived: sum of 2 quarters · filed 2022-02-14 | -$5.63M 10-Q · filed 2021-02-10 | -$7.41M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | -$1.77M 10-Q · filed 2022-02-14 | -$3.18M 10-Q · filed 2021-11-09 | -$4.97M derived: sum of 3 quarters · filed 2022-02-14 | -$5.79M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-06-30 | -$1.41M 10-Q · filed 2022-02-14 | -$3.20M derived: sum of 2 quarters · filed 2022-02-14 | -$4.02M derived: sum of 3 quarters · filed 2022-02-14 | -$5.72M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-03-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-24 | -$2.61M derived: sum of 2 quarters · filed 2021-06-24 | -$4.31M derived: sum of 3 quarters · filed 2021-06-24 | -$6.38M 10-K · filed 2021-06-24 | |
| 2019-12-31 | -$820.94K 10-Q · filed 2021-02-10 | -$2.53M derived: sum of 2 quarters · filed 2021-02-10 | -$4.59M 10-Q · filed 2021-02-10 | -$6.24M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-09-30 | -$1.71M 10-Q · filed 2020-10-28 | -$3.77M 10-Q · filed 2020-10-28 | -$5.42M derived: sum of 3 quarters · filed 2020-10-28 | -$7.44M derived: sum of 4 quarters · filed 2020-10-28 | |
| 2019-06-30 | -$2.07M 10-Q · filed 2020-08-11 | -$3.71M derived: sum of 2 quarters · filed 2020-08-11 | -$5.73M derived: sum of 3 quarters · filed 2020-08-11 | -$7.13M derived: sum of 4 quarters · filed 2020-08-11 | |
| 2019-03-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-25 | -$3.67M derived: sum of 2 quarters · filed 2020-06-25 | -$5.07M derived: sum of 3 quarters · filed 2020-06-25 | -$6.22M 10-K · filed 2020-06-25 | |
| 2018-12-31 | -$2.02M 10-Q · filed 2020-02-10 | -$3.42M derived: sum of 2 quarters · filed 2020-02-10 | -$4.57M 10-Q · filed 2020-02-10 | -$5.90M derived: sum of 4 quarters · filed 2020-02-10 | |
| 2018-09-30 | -$1.40M 10-Q · filed 2020-02-10 | -$2.55M 10-Q · filed 2019-11-01 | -$3.88M derived: sum of 3 quarters · filed 2020-02-10 | -$5.10M derived: sum of 4 quarters · filed 2020-02-10 | |
| 2018-06-30 | -$1.15M 10-Q · filed 2020-02-10 | -$2.48M derived: sum of 2 quarters · filed 2020-02-10 | -$3.70M derived: sum of 3 quarters · filed 2020-02-10 | -$5.01M derived: sum of 4 quarters · filed 2020-02-10 | |
| 2018-03-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | -$2.55M derived: sum of 2 quarters · filed 2019-07-01 | -$3.85M derived: sum of 3 quarters · filed 2019-07-01 | -$5.70M 10-K · filed 2019-07-01 | |
| 2017-12-31 | -$1.22M 10-Q · filed 2019-02-11 | -$2.53M derived: sum of 2 quarters · filed 2019-02-11 | -$4.37M 10-Q · filed 2019-02-11 | -$6.07M derived: sum of 4 quarters · filed 2019-02-11 | |
| 2017-09-30 | -$1.31M 10-Q · filed 2018-11-06 | -$3.15M 10-Q · filed 2018-11-06 | -$4.85M derived: sum of 3 quarters · filed 2018-11-06 | -$6.06M derived: sum of 4 quarters · filed 2018-11-06 | |
| 2017-06-30 | -$1.85M 10-Q · filed 2018-08-08 | -$3.54M derived: sum of 2 quarters · filed 2018-08-08 | -$4.75M derived: sum of 3 quarters · filed 2018-08-08 | -$7.02M derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-08 | -$2.91M derived: sum of 2 quarters · filed 2018-06-08 | -$5.17M derived: sum of 3 quarters · filed 2018-06-08 | -$7.31M 10-K · filed 2018-06-08 | |
| 2016-12-31 | -$1.21M 10-Q · filed 2018-02-01 | -$3.48M derived: sum of 2 quarters · filed 2018-02-01 | -$5.61M 10-Q · filed 2018-02-01 | -$6.87M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2016-09-30 | -$2.26M 10-Q · filed 2017-11-02 | -$4.40M 10-Q · filed 2017-11-02 | -$5.66M derived: sum of 3 quarters · filed 2017-11-02 | -$6.89M derived: sum of 4 quarters · filed 2017-11-02 | |
| 2016-06-30 | -$2.14M 10-Q · filed 2017-08-10 | -$3.39M derived: sum of 2 quarters · filed 2017-08-10 | -$4.63M derived: sum of 3 quarters · filed 2017-08-10 | -$5.88M derived: sum of 4 quarters · filed 2017-08-10 | |
| 2016-03-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | -$2.49M derived: sum of 2 quarters · filed 2017-06-28 | -$3.74M derived: sum of 3 quarters · filed 2017-06-28 | -$4.96M 10-K · filed 2017-06-28 | |
| 2015-12-31 | -$1.23M 10-Q · filed 2017-02-10 | -$2.48M derived: sum of 2 quarters · filed 2017-02-10 | -$3.70M 10-Q · filed 2017-02-10 | -$4.63M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2015-09-30 | -$1.25M 10-Q · filed 2016-11-10 | -$2.47M 10-Q · filed 2016-11-10 | -$3.40M derived: sum of 3 quarters · filed 2016-11-10 | -$5.00M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$1.22M 10-Q · filed 2016-08-11 | -$2.15M derived: sum of 2 quarters · filed 2016-08-11 | -$3.75M derived: sum of 3 quarters · filed 2016-08-11 | -$4.64M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | -$928.37K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-29 | -$2.53M derived: sum of 2 quarters · filed 2016-06-29 | -$3.42M derived: sum of 3 quarters · filed 2016-06-29 | -$6.98M 10-K · filed 2016-06-29 | |
| 2014-12-31 | -$1.60M 10-Q · filed 2016-02-04 | -$2.49M derived: sum of 2 quarters · filed 2016-02-04 | -$6.05M 10-Q · filed 2016-02-04 | -$13.71M derived: sum of 4 quarters · filed 2016-02-04 | |
| 2014-09-30 | -$888.19K 10-Q · filed 2015-11-16 | -$4.59M 10-Q · filed 2015-11-16 | -$12.11M derived: sum of 3 quarters · filed 2015-11-16 | -$14.38M derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | -$3.70M 10-Q · filed 2015-08-13 | -$11.22M derived: sum of 2 quarters · filed 2015-08-13 | -$13.49M derived: sum of 3 quarters · filed 2015-08-13 | -$16.84M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | -$7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-13 | -$9.79M derived: sum of 2 quarters · filed 2015-07-13 | -$13.14M derived: sum of 3 quarters · filed 2015-07-13 | -$13.44M 10-K · filed 2015-07-13 | |
| 2013-12-31 | -$2.27M 10-Q · filed 2015-02-10 | -$5.62M derived: sum of 2 quarters · filed 2015-02-10 | -$5.92M 10-Q · filed 2015-02-10 | -$8.69M derived: sum of 4 quarters · filed 2015-02-10 | |
| 2013-09-30 | -$3.35M 10-Q · filed 2014-11-10 | -$3.65M 10-Q · filed 2014-11-10 | -$6.42M derived: sum of 3 quarters · filed 2014-11-10 | -$6.11M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | -$303.50K 10-Q · filed 2014-08-14 | -$3.07M derived: sum of 2 quarters · filed 2014-08-14 | -$2.76M derived: sum of 3 quarters · filed 2014-08-14 | ||
| 2013-03-31 | -$2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | -$2.45M derived: sum of 2 quarters · filed 2014-07-15 | -$4.89M 10-K · filed 2014-07-15 | ||
| 2012-12-31 | $313.94K 10-Q · filed 2014-02-11 | -$2.13M 10-Q · filed 2014-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |